CollPlant Biotechnologies (CLGN) Preferred Shares (2020 - 2026)

CollPlant Biotechnologies has reported Preferred Shares for 7 years, with the latest figure at $127.5 million in Q1 2026.

• For the quarter ending Q1 2026, Preferred Shares rose 3.52% year-over-year to $127.5 million; the trailing twelve-month figure through Mar 2026 stood at $127.5 million (up 3.52% YoY), and the FY2025 full-year result was $126.4 million, up 2.93% from the prior year.
• Preferred Shares for Q1 2026 stood at $127.5 million, up from $126.4 million in the prior quarter.
• The five-year high for Preferred Shares was $127.5 million in Q1 2026, with the low at $116.0 million in Q1 2022.
• Historically, Preferred Shares has averaged $121.9 million across 5 years, with a median of $121.6 million in 2024.
• Annual changes were most pronounced in 2024 — Preferred Shares grew 1.43% — and 2026, when it rose 3.52%.
• CollPlant Biotechnologies' Preferred Shares stood at $118.1 million in 2022, then climbed by 2.51% to $121.1 million in 2023, then gained by 1.43% to $122.8 million in 2024, then rose by 2.93% to $126.4 million in 2025, then increased by 0.89% to $127.5 million in 2026.
• The last three Preferred Shares figures came in at $127.5 million (Q1 2026), $126.4 million (Q4 2025), and $126.4 million (Q3 2025), per Business Quant data.